Abstract
Background
Multimorbidity can be defined as the presence of more than one chronic condition in an individual. Research on multimorbidity has predominantly focused on older adults and few studies have examined multimorbidity in middle-aged people. The objectives of this study were to: 1) examine the prevalence of multimorbidity among middle-aged Canadians; and 2) examine the association between lifestyle factors (smoking, alcohol intake, physical activity) and multimorbidity in this age group.
Methods
In this analysis of the Canadian Longitudinal Study on Aging (CLSA) baseline data, we extracted data from 29,841 participants aged 45–64 years from a database of 51,338 people aged 45–85 years. Self-reported data on 27 chronic physical health conditions were used to derive different multimorbidity definitions. We estimated the prevalence of 3+ to 5+ chronic physical health conditions in different subgroups for descriptive purposes. Multivariable logistic regression analyses were performed to determine the association between socio-demographic and lifestyle factors, and multimorbidity using a 3+ multimorbidity case definition.
Result
We found that 39.6% (99% CI 38.4–40.7) of participants had three or more chronic conditions with a mean number of chronic condition of 2.41 (99% CI 2.37–2.46). The prevalence of multimorbidity increased with age from 29.7% in the 45–49-year-old age group to 52% in individuals aged 60–64 years. The prevalence of 4+ and 5+ chronic conditions was 24.5 and 14.2% respectively. Analyses indicated that female sex and low income were associated with higher odds of multimorbidity, whereas daily or weekly alcohol intake were associated with lower odds of multimorbidity. Exercise was not associated with multimorbidity. Results were similar when analyses were conducted separately for women and men.
Conclusions
Multimorbidity is not limited to older adults, but is a common phenomenon among middle-aged people. Longitudinal research is needed to better understand the temporal relationship between lifestyle factors and multimorbidity.
Keywords: Multimorbidity, Chronic disease, Chronic conditions, Socio-demographic factors, Lifestyle factors, CLSA
Background
Multimorbidity, the co-existence of multiple chronic conditions in an individual [1–3], has been identified as one of the major health system concerns of the twenty-first century [4, 5]. The aging of the large baby boomer cohort, coupled with increased survival from previously fatal medical conditions, means that a growing number of adults present with multiple coexisting chronic conditions. Although multimorbidity has been considered a health problem of older adults, a substantial number of young and middle-aged people also have multimorbidity [6–8]. Despite this fact, relatively few studies have examined multimorbidity among middle-aged people.
Research based on general population samples and samples of older adults shows that multimorbidity has a major impact on individuals and the health care system. Multimorbidity negatively affects the quality of life of younger and older adults [9, 10], and significantly increases the risk of disability and mortality among older adults [11–14]. Multimorbidity also complicates the medical treatment process because multiple specialties are involved. Thus, individuals with multimorbidity are at risk of repeated hospitalization, longer hospital stays, polypharmacy, and adverse drug events [15–18]. Overall, multimorbidity increases health care utilization and costs, creating a substantial economic burden for the healthcare system [4]. Early-onset multimorbidity would be expected to further complicate this scenario as it prolongs the period of time spent in poor health as people age.
The prevalence of multimorbidity has been estimated in many studies in countries such as the United States, Australia, the Netherlands, and Canada. Its prevalence has been found to vary widely across studies - from around 20–30% when the whole population is considered to 55 to 98% in studies focusing on older adults [2, 19]. Although much of the research on multimorbidity has been conducted in Western countries [2, 19], a study conducted in China suggests that multimorbidity is common in other parts of the world as well [20]. The variation in the prevalence of multimorbidity is primarily due to differences in data sources, study populations and the number and types of chronic conditions counted to define multimorbidity [21–24]. For example, in a study using national Canadian data (the Community Health Survey [CCHS] 2011/12 data), 12.9% of Canadians aged 20 years or over had two or more chronic conditions, whereas 3.9% had three or more chronic conditions [23]. The prevalence ranged from 3.1% among individuals aged 20 to 34 to 31.3% among individuals aged 65+. In contrast, a study that recruited participants from patients of family practitioners showed a much higher prevalence of two or more chronic conditions, ranging from 68 to 93% to 99% among patients aged 18 to 44, 45 to 64, and 65+, respectively [8].
Multimorbidity is strongly associated with several sociodemographic factors. Increasing age and living in poor socioeconomic condition are established risk factors of multimorbidity [1, 23–25]. In addition, women have been found to have a higher risk of having multimorbidity than men in many (albeit not all studies), although the argument has been made that the greater longevity in women may be responsible for this higher prevalence [2, 3, 24, 26, 27]. Sex differences in health care use may also account for this finding. Similarly, some studies indicate that there is an inverse relationship between education and multimorbidity [3, 22, 28].
Researchers have also examined the relationship between lifestyle factors (smoking, alcohol intake and physical activity) and multimorbidity, but findings have been inconsistent [29]. Smoking was associated with an increased likelihood of multimorbidity among middle-aged (40–59 years old) and older participants (60+ years old) in an Australian study [30], and among men, but not women in a Canadian study [31], but decreased likelihood of multimorbidity in a South African study [32]. Being sedentary versus exercising at a low, medium, or high level was associated with increased odds of multimorbidity among older participants, but not younger participants in one study [30], whereas in another study, being physically active was associated with decreased odds of multimorbidity only among older men, but not older women [33]. Yet other research shows no relationship between physical activity and multimorbidity [31, 34]. Alcohol consumption has been found not to be associated with multimorbidity [30, 31].
In sum, although multimorbidity has been examined extensively in older adults and general population samples, few studies have focused specifically on middle-aged individuals, particularly in Canada, and examined the prevalence of multimorbidity and potential lifestyle risk factors in this age group. The objectives of this study were, therefore: 1) to examine the prevalence of multimorbidity among middle-aged Canadians; and 2) to explore the association between lifestyle factors (smoking, alcohol consumption, and physical activity) and multimorbidity in this age group.
Methods
Data source
This study is based on an analysis of the Canadian Longitudinal Study on Aging (CLSA) survey data [35, 36]. The CLSA is a large, national, long-term, longitudinal study which is expected to continue for at least 20 years [35, 36]. The CLSA started the recruitment process in 2010 and completed baseline data collection in 2015. The CLSA has a total sample of 51,338 Canadian women and men who were 45 to 85 years old when recruited [35, 36]. Exclusion criteria for recruitment into the CLSA were: Resident of the three territories of Canada; living on federal First Nations reserves or other First Nations settlements in the provinces; full-time members of the Canadian Armed Forces; living in long-term care institution; and cognitive impairment [35, 36].
The CLSA is comprised of a Tracking and a Comprehensive cohort. The Tracking cohort includes 21,241 participants who were randomly selected from across the 10 Canadian provinces [36]. This cohort responded to a survey only that was administered using computer-assisted telephone interview (CATI) software [37]. The Comprehensive cohort is comprised of 30,097 participants who were randomly selected from within a 25-km radius (or 50 km radius in the case of smaller cities) from one of 11 Data Collection Sites (DCS) in 7 provinces (Vancouver, Victoria, Calgary, Winnipeg, Hamilton, Ottawa, Montréal, Sherbrooke, Halifax, and St. John’s) [35]. Comprehensive cohort participants participated in computer-assisted interviews, physical assessments and provided biological samples (i.e., blood, urine) [38]. Detailed information about the sampling strategy and study design has been published elsewhere [35, 36]. Both Tracking and Comprehensive cohorts were re-interviewed with CATI software approximately 18 months after the baseline interview with a short Maintaining Contact Questionnaire [39]. Most of the variables used in the present study were derived from the baseline questionnaire; however, as physical activity was assessed only in the Maintaining Contact Questionnaire, this variable was derived from that questionnaire. Follow-up data were not yet available at the time this study was conducted.
Participants provided written informed consent to participate in the CLSA. This study was approved by the Health Research Ethics Board at the University of Manitoba.
Study sample
As the focus of the present study was middle-aged Canadians, we included only individuals aged 45 to 64. In the total CLSA baseline sample, 12,390 and 17,541 participants from the Tracking and Comprehensive cohort, respectively were aged 45–64 years. Thus, this study included 29,841 respondents aged 45–64 years.
Study variables
Multimorbidity
To determine the occurrence of chronic health conditions, respondents were asked whether a doctor ever told them that they have any one of 34 chronic conditions. From the list of chronic conditions, we included the following 27 physical health conditions: osteoarthritis, rheumatoid arthritis, other arthritis, asthma, other chronic lung diseases (emphysema, chronic bronchitis, chronic obstructive pulmonary disease, and chronic changes in lungs due to smoking), hypertension, diabetes, chronic heart disease (congestive heart failure), ischemic heart disease, peripheral vascular disease, cerebrovascular disease, Parkinson’s disease, multiple sclerosis, epilepsy, migraine, intestinal or stomach ulcers, chronic bowel disorders (Crohn’s Disease, ulcerative colitis, or Irritable Bowel Syndrome), cataract, glaucoma, macular degeneration, cancer, allergy, osteoporosis, back problem, hypothyroidism or myxedema, hyperthyroidism or Graves’ disease, and kidney disease or kidney failure.
The types of chronic conditions included in multimorbidity studies varies widely, as does the number of chronic conditions, which have ranged from 11 to 130 [19]. We included the 27 chronic physical health conditions listed above as they either fit with the definition of a chronic condition or have been included in previous multimorbidity studies [2, 19, 24]. In some instances, we collapsed related chronic conditions to bring them under the same headings. For example, angina and myocardial infarction were collapsed into ischaemic heart diseases; transient ischemic attack and cerebrovascular accident were collapsed as cerebrovascular diseases.
Multimorbidity was defined in this study as the presence of three or more chronic physical health conditions in an individual, consistent with previous research [23, 24]. We also estimated the prevalence of 4+ and 5+ chronic physical health conditions for descriptive purposes to better understand the chronic disease burden among middle-aged people.
Socio-demographic and lifestyle variables
Socio-demographic and lifestyle factors related data were based on self-report, and included respondents’ age, sex, educational level, annual household income, smoking habit, alcohol intake, and physical activity.
Age
Participants’ age was calculated from their date of birth. It was converted into an ordinal variable with the following age groups: 45–49, 50–54, 55–59 and 60–64.
Sex
Participants were asked about their sex, with men coded as 1 and women coded as 2.
Income
The socioeconomic status of the participants was assessed with household income. Participants were asked: “What is your best estimate of the total household income received by all household members, from all sources, before taxes and deductions, in the past 12 months?” [37]. This variable was categorized as follows: 1 = Less than $20,000; 2 = $20,000 or more, but less than $50,000; 3 = $50,000 or more, but less than $100,000; 4 = $100,000 or more, but less than $150,000; and 5 = $150,000 or more. There were some missing values (n = 1393) which were coded as 6 = “No Response”.
Education
The level of education was obtained from two variables. After first responding to whether they had graduated from high school, participants were asked: “Have you received any other education that could be counted towards a degree, certificate, or diploma from an educational institution?” [37]. Respondents who said “No” were considered as having an education which was “high school or less”. Participants who said “Yes” were further asked the following question to know the level of education achieved: “What is the highest degree, certificate, or diploma you have obtained?”: no post-secondary degree, certificate, or diploma; trade certificate or diploma from a vocational school or apprenticeship training, non-university certificate or diploma from a community college, school of nursing, etc.; university certificate below bachelor’s level; Bachelor’s degree; and university degree or certificate above bachelor’s degree [37]. An ordinal variable was derived from these questions with the following categories: high school or less; non-college or non-university degree; and college or university degree.
Smoking
Participants were asked: “At the present time, do you smoke cigarettes daily, occasionally or not at all?” with the following response options: Daily (at least one cigarette every day for the past 30 days); Occasionally (at least one cigarette in the past 30 days, but not every day); Not at all (you did not smoke at all in the past 30 days); Don’t know/No answer, and Refused [37]. This variable was recoded as 0 = non-smoker (not at all), 1 = smoker (occasionally or daily) and 2 = no response.
Alcohol
Participants were asked: “About how often during the past 12 months did you drink alcohol?” with the following response options: Almost every day (including 6 times a week); 4–5 times a week; 2–3 times a week; Once a week, 2–3 times a month; About once a month; Less than once a month; Never; Don’t know/No answer, and Refused [37]. This variable was recoded as follows: 0 = No drinker, 1 = Occasional drinker (about once a month or less than once a month), 2 = Weekly drinker (once a week or 2–3 times a month), 3 = Daily drinker (almost every day or 4–5 times a week), and 4 = no response.
Physical activity
Participants were asked: “Over the past 7 days, how often did you engage in moderate sports or recreational activities such as ballroom dancing, hunting, skating, golf without a cart, softball or other similar activities?” with the following response options: Never; Seldom (1 to 2 days); Sometimes (3 to 4 days); Often (5 to 7 days); Don’t know/No answer, and Refused [39]. This variable was recoded as follows: 0 = never, 1 = seldom, 2 = sometimes or often, and 3 = no response.
Covariates
CLSA participants’ area of residence (urban/rural) and province of residence, depressive symptoms, and functional status were included as covariates in the multivariable analyses. Area of residence and province of residence we controlled for to offset the effect of any regional variation and the study design. Area of residence was defined as rural or urban. This variable was provided in the dataset as: Rural; Urban core; Urban fringe; Urban population centre outside a Census Metropolitan Area and Census Agglomeration; Secondary core; and Postal code link to dissemination area. The variable was recoded as 0 = rural and 1 = urban, with the latter including all non-rural categories. All ten Canadian provinces were included in the analyses, as participants were recruited from all provinces. The inclusion of the ten provinces as a covariate in analyses is recommended by CLSA, given the study’s sampling design [40].
Given that our definition of multimorbidity focused on physical health problems, we included depressive symptoms as a covariate to control for the possible confounding effect of mental health problems in the relationship between socio-demographic and lifestyle factors and multimorbidity. Depressive symptoms were measured using the Center for Epidemiologic Studies Short Depression Scale (CES-D10) [41]. A depressive symptom score was derived based on 10 questions regarding feelings of depression, loneliness, hopefulness for the future, and restless sleep where each question has four response options (all of the time, occasionally, some of the time, rarely or never) [41]. The total score can range from 0 to 30. We recoded this scale as no depressive symptoms (score 0–9) and depressive symptoms (score 10 or more).
Functional status was controlled for as it is related to both socio-demographic characteristics and multimorbidity. Controlling for functional status therefore allows examining the unique association between socio-demographic and lifestyle factors and multimorbidity. A modified version of the Older Americans Resources and Services (OARS) Multidimensional Assessment Questionnaire was used to assess functional limitations [42]. Functional status was categorized as no, mild, moderate, severe and total functional limitations. Considering the comparatively younger cohort of our study, we collapsed the mild, moderate, severe and total functional limitation categories to create a no functional limitations and some limitations variable.
Statistical analyses
The prevalence of multimorbidity for the middle-aged population, stratified by all the variables was first estimated. In addition, the mean number of chronic conditions was calculated for each subgroup. We were also interested to measure the most common chronic conditions occurring in middle-aged people. We, therefore, estimated the prevalence of all 27 chronic conditions for the total sample, as well as stratified by sex.
To identify the factors independently associated with multimorbidity, we performed multivariable logistic regression analysis where we included the socio-demographic and lifestyle variables and controlled for covariates (area of residence, provinces, depression, and functional limitations). Separate analyses were also conducted for men and women. For these analyses, we used 3+ chronic physical health conditions as the case definition. Sensitivity analyses were also conducted using the 4+ and 5+ multimorbidity definitions.
To make the estimates generalizable to the Canadian population and address the complexity of the CLSA survey design, we used trimmed weights in the descriptive analyses and analytic weights in regression analyses, as recommended by CLSA [40]. Weights are calculated by CLSA and are provided in the dataset that is released to researchers [40]. Statistical analyses and data management were performed using SAS software package Version 9.4 (SAS Institute Inc., Cary, North Carolina, USA).
Results
Sample description
Men (49.4%) and women (50.6%) were equally represented in the sample with an average age of 54.6 years (99% confidence interval [CI] 54.44–54.69) (Table 1). Most of the respondents had either a college or university degree (63.9%) (Table 1). A substantial proportion of respondents (84.3, 99% CI 83.47–85.21) reported at least one of the chronic physical health conditions included in this study, with an overall average of 2.41 (99% CI 2.37–2.46) chronic conditions per person (Table 1).
Table 1.
Sample description
| Variables | Percentage (%) | Mean chronic conditions (99% CI) |
|---|---|---|
| Total sample | 100 | 2.41 (2.37, 2.46) |
| Sex | ||
| Male | 49.40 | 2.14 (2.08, 2.20) |
| Female | 50.60 | 2.68 (2.61, 2.75) |
| Age group | ||
| 45–49 | 20.50 | 1.95 (1.85, 2.05) |
| 50–54 | 34.38 | 2.14 (2.06, 2.22) |
| 55–59 | 21.23 | 2.64 (2.54, 2.74) |
| 60–64 | 23.89 | 3.00 (2.91, 3.10) |
| Education | ||
| Either college or university degree | 63.90 | 2.27 (2.21, 2.32) |
| No college or university degree | 19.23 | 2.59 (2.48, 2.71) |
| High school or less | 16.87 | 2.77 (2.63, 2.90) |
| Household income | ||
| < $20,000 | 4.00 | 3.83 (3.54, 4.13) |
| $20,000 to < $50,00 | 15.58 | 2.92 (2.78, 3.05) |
| $50,000 to < $100,000 | 33.73 | 2.39 (2.31, 2.47) |
| $100,000 to < $150,000 | 22.64 | 2.18 (2.09, 2.27) |
| < $150,000 or more | 20.10 | 1.96 (1.87, 2.06) |
| No response | 3.95 | 2.86 (2.60, 3.12) |
| Smoking status | ||
| Non-smoker | 55.22 | 2.46 (2.39, 2.52) |
| Smoker | 12.65 | 2.71 (2.55, 2.86) |
| No response | 31.13 | 2.23 (2.17, 2.29) |
| Alcohol intake | ||
| Never | 10.11 | 3.13 (2.96, 3.30) |
| Occasional | 20.50 | 2.78 (2.66, 2.90) |
| Weekly | 23.40 | 2.25 (2.16, 2.35) |
| Daily | 43.95 | 2.16 (2.10, 2.23) |
| No response | 2.04 | 2.47 (2.17, 2.77) |
| Moderate physical activity | ||
| Never | 78.89 | 2.44 (2.39, 2.49) |
| Seldom | 8.31 | 2.12 (1.97, 2.27) |
| Sometimes or often | 4.80 | 2.11 (1.93, 2.30) |
| No response | 8.01 | 2.66 (2.47, 2.84) |
| Area of residence | ||
| Urban | 78.69 | 2.41 (2.36, 2.47) |
| Rural | 21.31 | 2.42 (2.30, 2.53) |
| Province of residence | ||
| Alberta | 9.86 | 2.37 (2.26, 2.48) |
| British Columbia | 13.85 | 2.47 (2.39, 2.55) |
| Manitoba | 3.34 | 2.31 (2.20, 2.42) |
| New Brunswick | 2.40 | 2.68 (2.46, 2.90) |
| Newfoundland and Labrador | 1.74 | 2.58 (2.42, 2.74) |
| Nova Scotia | 3.03 | 2.47 (2.32, 2.63) |
| Ontario | 38.02 | 2.47 (2.37, 2.57) |
| Prince Edward Island | 0.44 | 2.41 (2.20, 2.61) |
| Quebec | 24.57 | 2.29 (2.20, 2.38) |
| Saskatchewan | 2.76 | 2.39 (2.19, 2.58) |
| Depression | ||
| No depression | 83.35 | 2.24 (2.19, 2.29) |
| Depressive symptoms | 16.65 | 3.25 (3.10, 3.39) |
| Functional limitations | ||
| No limitations | 93.50 | 2.25 (2.21, 2.30) |
| Some limitations | 6.50 | 4.60 (4.35, 4.85) |
Note: Weighted percentages and means are shown
Prevalence of multimorbidity
The crude prevalence of multimorbidity, defined as three or more chronic conditions in an individual, for the full study sample was 39.6% (99% CI 38.44–40.74). The prevalence of 4+ and 5+ chronic conditions was 24.5% (99% CI 23.52–25.54) and 14.2% (99% CI 13.37–14.96) respectively (Table 2). The prevalence of multimorbidity increased steadily with age, being 29.7% in participants aged 45–49 years, 33.7% in those aged 50–54 years, 44.8% in those aged 55–59 years and 52% in those aged 60–64 years (Table 2). This pattern was evident for all multimorbidity definitions - from 3+ to 5+ chronic conditions (Fig. 1). The prevalence of multimorbidity was higher in women (45, 99% CI 43.32–46.62) than in men (34.1, 99% CI 32.50–35.67). The prevalence of multimorbidity was slightly lower in individuals reporting higher education (Table 2). We found an inverse relationship between multimorbidity and income. The prevalence of multimorbidity decreased steadily as income increased (Table 2). The prevalence of multimorbidity was slightly higher among participants who never smoked compared to smokers, those with a daily alcohol consumption, and those who never exercised. Similar patterns across sociodemographic and lifestyle factors emerged irrespective of the multimorbidity definition used (3+ to 5+) (Table 2).
Table 2.
Prevalence of multimorbidity across socio-demographic characteristics and lifestyle variables
| Variables | Prevalence of multimorbidity (weighted %, 99 CI) | ||
|---|---|---|---|
| 3+ chronic conditions | 4+ chronic conditions | 5+ chronic conditions | |
| Total sample | 39.59 (38.44, 40.74) | 24.53 (23.52, 25.54) | 14.17 (13.37, 14.96) |
| Sex | |||
| Male | 34.09 (32.50, 35.67) | 19.65 (18.33, 20.97) | 10.65 (9.66, 11.65) |
| Female | 44.97 (43.32, 46.62) | 29.30 (27.79, 30.80) | 17.61 (16.36, 18.87) |
| Age group | |||
| 45–49 | 29.70 (27.10, 32.30) | 15.89 (13.75, 18.02) | 8.62 (6.97, 10.27) |
| 50–54 | 33.65 (31.64, 35.66) | 19.69 (17.98, 21.40) | 10.99 (9.66, 12.32) |
| 55–59 | 44.81 (42.40, 47.22) | 28.81 (26.62, 31.00) | 16.33 (14.57, 18.10) |
| 60–64 | 52.00 (49.84, 54.16) | 35.11 (33.04, 37.18) | 21.60 (19.82, 23.38) |
| Education | |||
| College/university degree | 37.08 (35.67, 38.50) | 21.72 (20.52, 22.91) | 11.94 (11.01, 12.87) |
| Non-college/university degree | 41.94 (39.33, 44.55) | 27.73 (25.37, 30.09) | 17.02 (15.07, 18.97) |
| High school or less | 46.43 (43.48, 49.37) | 31.54 (28.76, 34.32) | 19.40 (17.06, 21.73) |
| Household income | |||
| < $20,000 | 60.31 (55.18, 65.43) | 46.58 (41.38, 51.79) | 36.50 (31.47, 41.53) |
| $20,000 to < $50,00 | 49.54 (46.67, 52.40) | 33.86 (31.09, 36.64) | 21.08 (18.68, 23.47) |
| $50,000 to < $100,000 | 39.96 (37.97, 41.95) | 24.64 (22.91, 26.38) | 13.60 (12.22, 14.97) |
| $100,000 to < $150,000 | 35.03 (32.61, 37.44) | 19.92 (17.88, 21.96) | 10.49 (8.96, 12.03) |
| < $150,000 or more | 30.49 (28.00, 32.99) | 16.05 (14.08, 18.03) | 8.03 (6.63, 9.44) |
| No response | 48.71 (43.40, 54.02) | 33.97 (28.88, 39.07) | 21.61 (16.98, 26.24) |
| Smoking status | |||
| Non-smoker | 40.46 (38.91, 42.00) | 25.14 (23.78, 26.51) | 14.57 (13.48, 15.67) |
| Smoker | 43.98 (40.69, 47.27) | 29.40 (26.40, 32.39) | 18.86 (16.29, 21.43) |
| No response | 36.38 (34.85, 37.92) | 21.56 (20.25, 22.88) | 11.64 (10.65, 12.64) |
| Alcohol intake | |||
| Never | 50.57 (46.99, 54.15) | 35.95 (32.53, 39.36) | 24.96 (21.86, 28.06) |
| Occasional | 46.48 (43.88, 49.07) | 31.11 (28.73, 33.49) | 18.73 (16.74, 20.72) |
| Weekly | 36.81 (33.53, 36.96) | 21.86 (19.84, 23.89) | 12.28 (10.68, 13.89) |
| Daily | 35.24 (33.53, 36.96) | 20.18 (18.73, 21.63) | 10.41 (9.33, 11.49) |
| No response | 41.67 (34.12, 49.23) | 26.18 (19.77, 32.60) | 17.77 (12.20, 23.34) |
| Moderate physical activity | |||
| Never | 40.08 (38.79, 41.38) | 24.87 (23.73, 26.00) | 14.33 (13.43, 15.24) |
| Seldom | 33.57 (29.73, 37.41) | 18.72 (15.50, 21.94) | 10.28 (7.80, 12.76) |
| Sometimes or often | 35.22 (30.33, 40.12) | 19.39 (15.39, 23.40) | 11.36 (8.10, 14.62) |
| No response | 43.67 (39.32, 48.01) | 30.34 (26.27, 34.41) | 18.35 (14.90, 21.80) |
| Area of residence | |||
| Urban | 39.57 (38.32, 40.83) | 24.26 (23.16, 25.36) | 14.10 (13.22, 14.98) |
| Rural | 39.67 (36.92, 42.43) | 25.52 (23.07, 27.96) | 14.45 (12.51, 16.40) |
| Province of residencea | |||
| Alberta | 39.22 (36.47, 41.98) | 24.20 (21.77, 26.62) | 14.31 (12.32, 16.30) |
| British Columbia | 41.28 (39.25, 43.32) | 25.28 (23.51, 27.06) | 15.10 (13.66, 16.54) |
| Manitoba | 37.43 (34.71, 40.16) | 22.74 (20.38, 25.09) | 13.03 (11.17, 14.89) |
| New Brunswick | 43.30 (38.64, 47.96) | 28.70 (24.47, 32.92) | 18.66 (15.01, 22.31) |
| Newfoundland and Labrador | 44.81 (40.84, 48.77) | 27.18 (23.67, 30.70) | 15.95 (13.07, 18.83) |
| Nova Scotia | 41.25 (37.58, 44.92) | 25.01 (21.82, 28.20) | 14.43 (11.84, 17.01) |
| Ontario | 40.53 (38.13, 42.94) | 25.84 (23.71, 27.97) | 14.64 (12.94, 16.34) |
| Prince Edward Island | 40.63 (35.42, 45.84) | 24.73 (20.18, 29.29) | 13.94 (10.28, 17.60) |
| Quebec | 36.73 (34.58, 38.88) | 21.94 (20.09, 23.80) | 12.49 (11.03, 13.94) |
| Saskatchewan | 39.19 (34.66, 43.71) | 23.27 (19.41, 27.13) | 13.79 (10.63, 16.94) |
| Depression | |||
| No depression | 36.33 (35.08, 37.58) | 21.49 (20.42, 22.56) | 11.75 (10.92, 12.58) |
| Depressive symptoms | 55.05 (52.17, 57.94) | 38.76 (35.97, 41.55) | 25.77 (23.28, 28.27) |
| Functional limitations | |||
| No limitations | 36.90 (35.73, 38.08) | 21.81 (20.81, 22.82) | 11.87 (11.09, 12.65) |
| Some limitations | 75.79 (72.04, 79.53) | 61.03 (56.65, 65.41) | 45.20 (40.69, 49.72) |
Note: Weighted percentages are shown. aProvinces are listed in alphabetic order
Fig. 1.
The prevalence of 3+ to 5+ chronic conditions increases with age
We also estimated the mean number of chronic conditions in different subgroups of the sample. For example, consistent with the prevalence estimates, the mean number of chronic conditions increased with age and was higher in women (2.7, 99% CI 2.61–2.75) than men (2.1, 99% CI 2.08–2.20) (Table 1).
Common chronic conditions
Among the 27 chronic conditions included in the study, allergy was the most prevalent chronic condition (40.2, 99% CI 39.07–41.40) (Table 3). Hypertension 26.2% (99% CI 25.19–27.23) and back problem 24.7% (99% CI 23.71–25.73) were the second and third most common conditions (Table 3). Some other common chronic conditions were osteoarthritis (18.9%), diabetes (12.9%), migraine (15.6%), asthma (12.5%) and other arthritis (11.4%) (Table 3). When the prevalence of chronic conditions was stratified by sex, men were found to have a higher prevalence of hypertension (28.5% vs. 24%), back problems (26.2% vs. 23.3%), diabetes (13.7% vs. 12.2%), stomach/intestinal ulcer (6.4% vs. 6.1%), heart disease (CHF) (7% vs. 4%), ischemic heart disease (5.8% vs.2.7%), cerebrovascular disease (2.4% vs. 1.8%), kidney disease (2.1% vs. 1.5%), and Parkinson disease (0.3% vs. 0.1%) (Table 3). For the other conditions, women had a higher prevalence than men (Table 3).
Table 3.
Prevalence of specific chronic conditions
| Chronic condition | Prevalence (weighted %, 99 CI) | ||
|---|---|---|---|
| Total sample | Men | Women | |
| Allergy | 40.23 (39.07, 41.40) | 34.38 (32.77, 35.98) | 54.06 (52.40, 55.72) |
| Hypertension | 26.21 (25.19, 27.23) | 28.47 (26.99, 29.96) | 24.00 (22.59, 25.40) |
| Back problem | 24.72 (23.71, 25.73) | 26.17 (24.71, 27.63) | 23.30 (21.91, 24.70) |
| Osteoarthritis | 18.88 (17.96, 19.81) | 15.07 (13.85, 16.28) | 22.60 (21.22, 23.98) |
| Migraine | 15.59 (14.71, 16.46) | 8.92 (7.92, 9.91) | 22.09 (20.69, 23.50) |
| Diabetes | 12.90 (12.11, 13.68) | 13.65 (12.53, 14.76) | 12.17 (11.07, 13.26) |
| Asthma | 12.48 (11.71, 13.26) | 11.07 (10.01, 12.13) | 13.86 (12.73, 14.99) |
| Other arthritis | 11.43 (10.65, 12.21) | 9.70 (8.69, 10.72) | 13.12 (11.94, 14.30) |
| Cancer | 9.20 (8.52, 9.88) | 7.49 (6.62, 8.35) | 10.87 (9.83. 11.92) |
| Chronic bowel disease (IBS, IBD) | 7.96 (7.32, 8.59) | 5.33 (4.58, 6.08) | 10.51 (9.51, 11.52) |
| Cataract | 7.88 (7.28, 8.48) | 7.00 (6.19, 7.82) | 8.74 (7.87, 9.62) |
| Hypothyroidism | 7.07 (6.43, 7.71) | 3.19 (2.54, 3.84) | 10.86 (9.79, 11.94) |
| Stomach/intestinal ulcer | 6.24 (5.67, 6.81) | 6.40 (5.56, 7.24) | 6.07 (5.30, 6.85) |
| Heart disease/CHF | 5.46 (4.95, 5.97) | 6.95 (6.14, 7.75) | 4.01 (3.38, 4.64) |
| Osteoporosis | 5.24 (4.72, 5.75) | 1.77 (1.34, 2.21) | 8.62 (7.70, 9.54) |
| Peripheral vascular disease | 4.67 (4.18, 5.16) | 4.29 (3.62, 4.96) | 5.04 (4.32, 5.75) |
| Emphysema/chronic bronchitis/COPD | 4.46 (4.00, 4.93) | 4.17 (3.54, 4.80) | 4.74 (4.07, 5.42) |
| Ischemic heart disease | 4.22 (3.75, 4.70) | 5.82 (5.05, 6.59) | 2.66 (2.11, 3.22) |
| Hyperthyroidism | 4.04 (3.69, 4.40) | 2.02 (1.62, 2.42) | 6.03 (5.44, 6.61) |
| Rheumatoid arthritis | 3.81 (3.34, 4.28) | 3.42 (2.79, 4.05) | 4.19 (3.49, 4.90) |
| Glaucoma | 2.11 (1.79, 2.43) | 1.93 (1.50, 2.36) | 2.28 (1.81, 2.75) |
| Cerebrovascular disease | 2.10 (1.77, 2.44) | 2.41 (1.88, 2.94) | 1.80 (1.39, 2.22) |
| Kidney disease | 1.82 (1.53, 2.11) | 2.12 (1.65, 2.59) | 1.53 (1.18, 1.87) |
| Macular degeneration | 1.51 (1.23, 1.79) | 1.40 (1.03, 1.76) | 1.61 (1.19, 2.03) |
| Epilepsy | 0.97 (0.74, 1.19) | 0.89 (0.59, 1.18) | 1.05 (0.71, 1.39) |
| Multiple sclerosis | 0.66 (0.51, 0.82) | 0.41 (0.24, 0.57) | 0.92 (0.65, 1.18) |
| Parkinson disease | 0.19 (0.09, 0.30) | 0.28 (0.08, 0.47) | 0.11 (0.02, 0.19) |
Note: Weighted percentages are shown. IBS = Irritable Bowel Syndrome, IBD = Inflammatory Bowel Disease, CHF = Congestive Heart Failure, COPD = Chronic Obstructive Pulmonary Disease
Regression results
Multivariable logistic models using 3+ chronic physical health conditions versus < 3 conditions as the outcome variable showed that multimorbidity was significantly associated with several socio-demographic factors (Table 4). Female sex and lower income were associated with higher odds of 3+ chronic conditions, whereas weekly and daily alcohol intake was associated with lower odds of having multimorbidity. Education, smoking, and physical activity were not significantly associated with multimorbidity. Significant associations also emerged for the covariates, with depressive symptoms and functional limitations associated with higher odds of multimorbidity. Results were similar for women and men (Table 4). Similar results were also obtained in the sensitivity analyses in which we used 4+ and 5+ chronic conditions as outcome variables.
Table 4.
Multivariable analyses of the association between sociodemographic and lifestyle characteristics and multimorbidity
| Variables | 3+ vs. < 3 Chronic Physical Health Conditions Adjusted Odds Ratios (99% CI) |
||
|---|---|---|---|
| Total sample | Men | Women | |
| Sex | |||
| Male | 1 | – | – |
| Female | 1.48 (1.38,1.59) | – | – |
| Age group | |||
| 45–49 | 1 | 1 | 1 |
| 50–54 | 1.29 (1.16,1.44) | 1.33 (1.13,1.58) | 1.27 (1.10,1.47) |
| 55–59 | 1.98 (1.78,2.21) | 2.06 (1.74,2.43) | 1.93 (1.66,2.23) |
| 60–64 | 2.79 (2.50,3.11) | 2.76 (2.34,3.24) | 2.84 (2.44,3.29) |
| Education | |||
| College/university degree | 1 | 1 | 1 |
| Non-college/university degree | 1.07 (0.98,1.18) | 1.14 (1.00,1.30) | 1.00 (0.88,1.14) |
| High school or less | 1.04 (0.94,1.15) | 1.08 (0.93,1.27) | 0.99 (0.86,1.14)) |
| Household income | |||
| ≥$150,000 | 1 | 1 | 1 |
| $100,000 to < $150,000 | 1.03 (0.93,1.15) | 0.97 (0.83,1.13) | 1.10 (0.94,1.28) |
| $50,000 to < $100,000 | 1.12 (1.01,1.25) | 1.11 (0.96,1.28) | 1.14 (0.98,1.22) |
| $20,000 to < $50,00 | 1.26 (1.11,1.43) | 1.25 (1.03,1.51) | 1.27 (1.07,1.51) |
| < $20,000 | 1.61 (1.32,1.96) | 1.54 (1.14,2.07) | 1.69 (1.29,2.21) |
| No response | 1.20 (1.10,1.45) | 1.20 (0.90,1.61) | 1.21 (0.95,1.54) |
| Smoking status | |||
| Non-smoker | 1 | 1 | 1 |
| Smoker | 0.97 (0.87,1.09) | 0.94 (0.80,1.11) | 1.00 (0.86,1.17) |
| No response | 0.84 (0.78,0.91) | 0.76 (0.67,0.85) | 0.92 (0.83,1.02) |
| Alcohol intake | |||
| Never | 1 | 1 | 1 |
| Occasional | 0.99 (0.87,1.13) | 1.01 (0.83,1.23) | 0.96 (0.81,1.15) |
| Weekly | 0.75 (0.66,0.86) | 0.83 (0.68,1.00) | 0.70 (0.58,0.83) |
| Daily | 0.69 (0.61,0.77) | 0.71 (0.60,0.84) | 0.67 (0.56,0.80) |
| No response | 0.78 (0.61,1.01) | 0.92 (0.61,1.39) | 0.69 (0.50,0.95) |
| Moderate physical activity | |||
| Sometimes or often | 1 | 1 | 1 |
| Seldom | 0.98 (0.80,1.20) | 0.91 (0.68,1.22) | 1.07 (0.81,1.41) |
| Never | 1.12 (0.94,1.32) | 1.02 (0.80,1.29) | 1.23 (0.98,1.55) |
| No response | 1.08 (0.87,1.33) | 0.95 (0.70,1.28) | 1.23 (0.92,1.64) |
| Area of residence | |||
| Urban | 1 | 1 | 1 |
| Rural | 0.94 (0.85,1.04) | 0.90 (0.77,1.04) | 0.97 (0.85,1.11) |
| Province of residencea | |||
| Quebec | 1 | 1 | 1 |
| Alberta | 1.16 (1.01,1.34) | 1.07 (0.86,1.33) | 1.25 (1.03,1.51) |
| British Columbia | 1.28 (1.13,1.44) | 1.28 (1.07,1.52) | 1.28 (1.09,1.50) |
| Manitoba | 1.07 (0.93,1.24) | 1.13 (0.91,1.40) | 1.03 (0.85,1.24) |
| New Brunswick | 1.21 (0.97,1.50) | 0.98 (0.71,1.37) | 1.44 (1.07,1.94) |
| Newfoundland and Labrador | 1.35 (1.15,1.57) | 1.23 (098,1.54) | 1.44 (1.17,1.77) |
| Nova Scotia | 1.20 (1.04,1.38) | 1.30 (1.06,1.60) | 1.11 (0.91,1.34) |
| Ontario | 1.41 (1.26,1.58) | 1.44 (1.22,1.70) | 1.38 (1.19,1.61) |
| Prince Edward Island | 1.13 (0.88,1.44) | 1.02 (0.71,1.47) | 1.22 (0.86,1.71) |
| Saskatchewan | 1.05 (0.84,1.32) | 1.26 (0.90,1.75) | 0.89 (0.66,1.20) |
| Depression | |||
| No depressive symptoms | 1 | 1 | 1 |
| Depressive symptoms | 1.79 (1.62,1.97) | 1.74 (1.50,2.01) | 1.82 (1.61,2.07) |
| Functional limitations | |||
| No limitations | 1 | 1 | 1 |
| Some limitations | 2.94 (2.51,3.44) | 3.34 (2.51,4.44) | 2.78 (2.30,3.36) |
Note: aProvinces are listed in alphabetic order. Quebec was used as the reference group because it had the lowest prevalence of multimorbidity
Discussion
This study describes the epidemiology of multimorbidity among middle-aged people based on a national sample of Canadians. Our analysis showed that multimorbidity, defined in this study as having three or more chronic physical health conditions, is a very common occurrence among middle-aged Canadians. The prevalence of multimorbidity was 39.6% in our study population overall, and ranged from 29.7% in the 45–49-year-old age group to 52% in individuals aged 60–64 years. In addition, we found that a substantial proportion of middle-aged Canadians have four or more (24.5%) or five or more chronic physical health conditions (14.2%). Our finding is consistent with the arguments made by several authors that a substantial number of younger people live with multimorbidity. For example, based on a general population sample, Agborsangaya and colleagues [7] reported that 70% of people with multimorbidity were less than 65 years of age. Similarly, Barnett and colleagues [6] reported that the absolute number of people with multimorbidity was higher in those younger than 65 years compared to those older than 65 years of age.
Prevalence estimates of multimorbidity vary widely between studies and comparisons are complicated because definitions of multimorbidity differ (e.g., 2+ vs. 3+ chronic conditions, different number and types of chronic conditions) [43]. Moreover, many studies have focused on primary care samples [43]. As compared to a previous Canadian study that also used a national, general population sample [23] and a 3+ multimorbidity definition, our prevalence estimates are much higher. That study showed that among Canadians aged 20 or older 3.9% had three or more chronic conditions. When examining the prevalence for specific age groups, 4.7% of 50 to 64 year old individuals had three or more chronic conditions. In that study, multimorbidity was defined based on nine chronic conditions. This is contrast to our study, where we included 27 chronic conditions. As has previously been noted, not surprisingly, prevalence rates are higher when more chronic conditions are included [43].
Including a wide range of chronic conditions is useful when focusing on middle-aged individuals as many conditions can significantly impact their lives. In this respect, research shows that the conditions that impact health care utilization differ between younger and older adults [44]. For example, having back problems and migraines was related to increased hospital use among Canadians under 60 years or age, but not among those over 60 years of age [44]. Chronic conditions also have labor force implications among working age people. Rees and Sabia [45] showed, for instance, that having migraines, one of the chronic conditions included in the present study, was associated with reduced labor force participation and lower wages among women.
The association between multimorbidity and lifestyle factors has, to date, received relatively little attention in previous research. In the present study, smoking was not related to multimorbidity. Findings regarding smoking and multimorbidity have been inconsistent in previous research, with one study showing it was negatively related to multimorbidity [31], whereas another study showed no statistically significant relationship [32]. As our measure focused on whether individuals currently smoked, it may be that those with chronic health conditions had stopped smoking. Physical activity was also not related to multimorbidity in the present study, consistent with previous research [31, 34], but contrary to other studies that found statistically significant associations. This discrepancy in findings may be due to the age of study participants; significant relationships between exercise and multimorbidity have been found for older adults, but not younger individuals [30–34].
We further found that alcohol consumption was negatively associated with multimorbidity, unlike previous research that showed no association [30, 32]. People who reported drinking daily or weekly had significantly lower odds of having multimorbidity than those who reported never drinking. This finding is interesting because some studies have shown that moderate alcohol use may have protective effects against some chronic diseases, such as dementia, ischemic heart disease, and stroke [46–48]. In contrast, a recent large meta-analysis showed that alcohol use was a leading risk factor for mortality [49]. A number of explanations may account for the positive association in our study. First, people with high alcohol use would be less likely to participate in a population study. Second, given the relationship between alcohol use and mortality, our sample would consist of relatively healthier individuals. Third, our analyses are cross-sectional in nature, and causality cannot be inferred. It is, therefore, possible that people with multimorbidity stopped drinking. Nevertheless, our finding warrants more research, especially longitudinal analyses to disentangle the temporal relationship between variables. Also, which amount and what kind of alcohol may exert protective effects against multimorbidity would need investigation.
Socio-demographic risk factors for multimorbidity have been studied extensively in previous studies, but some key findings from our study merit attention. First, consistent with previous studies, we found that women had higher odds of multimorbidity than men. Although an association of multimorbidity with female sex has consistently been reported in previous studies [2, 3, 24], an argument has been made that this could be due to the shorter life expectancy of men [3]. Given that selective survival could not be at play in the present study, our finding that the risk of multimorbidity is higher among women than men suggests that this sex difference is a real effect.
Second, like previous studies, we found that low income was strongly associated with multimorbidity [1, 6, 22, 25]. Barnett and colleagues [6], for example, reported that the onset of multimorbidity can occur 10 to 15 years earlier for individual in the lowest socioeconomic group. In the present study, individuals in the lowest income group had almost twice the odds of having multimorbidity compared to those in the highest income group. Education was not related to multimorbidity in the present study, however. This may be because the sample is relatively well educated overall. In the context of a relatively well educated population, income differences may be more important than educational background.
Our study has strengths that are worth mentioning. The sample of our study is a national selected, generalizable sample of the Canadian population. The prevalence and associated determinants we found are therefore generalizable to the overall middle-aged Canadian population. An important consideration is also that we were able to capture 27 chronic conditions while estimating the prevalence of multimorbidity. In contrast, most of the previous studies were based on only a limited number of chronic conditions. Despite these strengths, several limitations must also be acknowledged. First, our results may be subject to recall bias since the measure of multimorbidity was based on self-reports of clinical diagnosis. Second, as this study is mostly cross-sectional in nature, it can merely show associations and causation cannot be inferred. Third, although all the multivariable analyses were controlled for potential covariates, other confounders may exist, such as ethnic background. Finally, our lifestyle measures were broad. For example, the alcohol intake measure did not take into account what people are drinking.
Conclusions
Given the large number of aging baby boomers, it is important to understand the prevalence and risk factors of multimorbidity to guide clinical care and preventive strategies [50]. In this study, we have described the prevalence of multimorbidity in a national sample of middle-aged Canadians and examined whether lifestyle factors are associated with multimorbidity. The finding that multimorbidity has a high prevalence in this age group suggests the need to focus on prevention, as well as appropriate care and treatment of people with multimorbidity. Additionally, this study identified some areas that require further research, especially the need for longitudinal research on the possible effects of lifestyle on multimorbidity.
Acknowledgements
The Canadian Longitudinal Study on Aging is led by Drs. Parminder Raina, Christina Wolfson and Susan Kirkland.
Funding
This research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 9447 and the Canada Foundation for Innovation. This research has been conducted using the CLSA Baseline Tracking Dataset 3.2, Baseline Comprehensive Dataset 3.1, under Application Number 170304. The funders had no influence on the design of the study, data collection or analysis, interpretation of data and writing of manuscripts based on the data.
Availability of data and materials
The data used for this study cannot be made available by the authors, as Canadian Longitudinal Study on Aging (CLSA) data are released to researchers only with approval of the CLSA Data Access Committee for a specific project, and once ethics approval for the research project has been obtained from the appropriate Research Ethics Board, and a CLSA Access Agreement between the CLSA Custodian and the Applicant’s institution has been executed. Further information on the data access can be found at https://www.clsa-elcv.ca/data-access. This study was approved by the CLSA Data Access Committee and data were made available after approval was obtained from the Health Research Ethics Board at the University of Manitoba, and a CLSA Access Agreement was signed between the CLSA Custodian and the University of Manitoba.
Abbreviations
- CATI
Computer Assisted Telephone Interviewing
- CCHS
Canadian Community Health Survey
- CES-D10
Center for Epidemiologic Studies Short Depression
- CHF
Congestive Heart Failure
- CI
Confidence Interval
- CLSA
Canadian Longitudinal Study on Aging
- COPD
Chronic Obstructive Pulmonary Disease
- DCS
Data Collection Site
- IBD
Inflammatory Bowel Disease
- IBS
Irritable Bowel Syndrome
- OARS
Older Americans Resources and Services
Authors’ contributions
MNS and VM conceptualized the study, analyzed the data and co-wrote the manuscript. SS and PS made substantial contributions to the conception of the study and interpretation of data and were involved in the drafting of the manuscript. All authors read and approved the final manuscript and agreed to be accountable for all aspects of the work.
Ethics approval and consent to participate
This study received ethics approval from the Health Research Ethics Board at the University of Manitoba. Participants provided written informed consent for their participation in the Canadian Longitudinal Study on Aging.
Consent for publication
Not applicable.
Competing interests
The authors have no competing interests. The opinions expressed in this manuscript are the authors’ own and do not reflect the views of the Canadian Longitudinal Study on Aging.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Mohammad Nazmus Sakib, Email: sakibmn@myumanitoba.ca.
Shahin Shooshtari, Email: shahin.shooshtari@umanitoba.ca.
Philip St. John, Email: PStJohn@hsc.mb.ca.
Verena Menec, Email: verena.menec@umanitoba.ca.
References
- 1.Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28:516–523. doi: 10.1093/fampra/cmr013. [DOI] [PubMed] [Google Scholar]
- 2.Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10:430–439. doi: 10.1016/j.arr.2011.03.003. [DOI] [PubMed] [Google Scholar]
- 3.Marengoni A, Winblad B, Karp A, Fratiglioni L. Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health. 2008;98:1198–1200. doi: 10.2105/AJPH.2007.121137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy. 2016;9:143. doi: 10.2147/RMHP.S97248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Oliver D. 21st century health services for an ageing population: 10 challenges for general practice. Br J Gen Pract. 2012;62:396–397. doi: 10.3399/bjgp12X653435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43. doi: 10.1016/S0140-6736(12)60240-2. [DOI] [PubMed] [Google Scholar]
- 7.Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Public Health. 2012;12:201. doi: 10.1186/1471-2458-12-201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3:223–228. doi: 10.1370/afm.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51. doi: 10.1186/1477-7525-2-51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Nóbrega TC, Jaluul O, Machado AN, Paschoal SM, Filho JW. Quality of life and multimorbidity of elderly outpatients. Clinics. 2009;64:45–50. doi: 10.1590/S1807-59322009000100009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Marengoni A, Von Strauss E, Rizzuto D, Winblad B, Fratiglioni L. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Int Med. 2009;265:288–295. doi: 10.1111/j.1365-2796.2008.02017.x. [DOI] [PubMed] [Google Scholar]
- 12.St John PD, Tyas SL, Menec V, Tate R. Multimorbidity, disability, and mortality in community-dwelling older adults. Can Fam Physician. 2014;60:e272–e280. [PMC free article] [PubMed] [Google Scholar]
- 13.Kadam U, Croft P. Clinical multimorbidity and physical function in older adults: a record and health status linkage study in general practice. Fam Pract. 2007;24:412–419. doi: 10.1093/fampra/cmm049. [DOI] [PubMed] [Google Scholar]
- 14.Menotti A, Mulder I, Nissinen A, Giampaoli S, Feskens EJ, Kromhout D. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: the FINE study (Finland, Italy, Netherlands, elderly) J Clin Epi. 2001;54:680–686. doi: 10.1016/S0895-4356(00)00368-1. [DOI] [PubMed] [Google Scholar]
- 15.Boyd CM, Fortin M. Future of multimorbidity research: how should understanding of multimorbidity inform health system design? Public Health Rev. 2010;32:451–474. doi: 10.1007/BF03391611. [DOI] [Google Scholar]
- 16.Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Int Med. 2002;162:2269–2276. doi: 10.1001/archinte.162.20.2269. [DOI] [PubMed] [Google Scholar]
- 17.Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract. 2012;62:e821–e8e6. doi: 10.3399/bjgp12X659295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother. 2007;5:31–39. doi: 10.1016/j.amjopharm.2007.03.004. [DOI] [PubMed] [Google Scholar]
- 19.Prados-Torres A, Calderón-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epi. 2014;67:254–266. doi: 10.1016/j.jclinepi.2013.09.021. [DOI] [PubMed] [Google Scholar]
- 20.Wang HHX, Wang JJ, Wong SYS, Wong MCS, Li FJ, Wang PX, et al. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162,464 community household residents in southern China. BMC Med. 2014;12:188. doi: 10.1186/s12916-014-0188-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Fortin M, Hudon C, Haggerty J, van den Akker M, Almirall J. Prevalence estimates of multimorbidity: A comparative study of two sources. BMC Health Serv Res. 2010;10:111. doi: 10.1186/1472-6963-10-111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epi. 1998;51:367–375. doi: 10.1016/S0895-4356(97)00306-5. [DOI] [PubMed] [Google Scholar]
- 23.Roberts K, Rao D, Bennett T, Loukine L, Jayaraman G. Prevalence and patterns of chronic disease multimorbidity and associated determinants in Canada. Health Promot Chronic Dis Prev Can. 2015;35:87–94. doi: 10.24095/hpcdp.35.6.01. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9:e102149. doi: 10.1371/journal.pone.0102149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61:e12–e21. doi: 10.3399/bjgp11X548929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.van Oostrom SH, Picavet HSJ, van Gelder BM, Lemmens LC, Hoeymans N, van Dijk CE, et al. Multimorbidity and comorbidity in the Dutch population–data from general practices. BMC Public Health. 2012;12:715. doi: 10.1186/1471-2458-12-715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Britt HC, Harrison CM, Miller GC, Knox SA. Prevalence and patterns of multimorbidity in Australia. Med J Aust. 2008;189:72–77. doi: 10.5694/j.1326-5377.2008.tb01919.x. [DOI] [PubMed] [Google Scholar]
- 28.Nagel G, Peter R, Braig S, Hermann S, Rohrmann S, Linseisen J. The impact of education on risk factors and the occurrence of multimorbidity in the EPIC-Heidelberg cohort. BMC Public Health. 2008;8:384. doi: 10.1186/1471-2458-8-384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fabbri E, Zoli M, Gonzalez-Freire M, Salive ME, Studenski SA, Ferrucci L. Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc. 2015;16:640–647. doi: 10.1016/j.jamda.2015.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Taylor AW, Price K, Gill TK, Adams R, Pilkington R, Carrangis N, et al. Multimorbidity-not just an older person's issue: results from an Australian biomedical study. BMC Public Health. 2010;10:718. doi: 10.1186/1471-2458-10-718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fortin M, Haggerty J, Almirall J, Bouhali T, Sasseville M, Lemieux M. Lifestyle factors and multimorbidity: a cross sectional study. BMC Public Health. 2014;14(1):686. doi: 10.1186/1471-2458-14-686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Alaba O, Chola L. The social determinants of multimorbidity in South Africa. Int J Equity Health. 2013;12:63. doi: 10.1186/1475-9276-12-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Autenrieth CS, Kirchberger I, Heier M, Zimmermann A-K, Peters A, Döring A, et al. Physical activity is inversely associated with multimorbidity in elderly men: results from the KORA-age Augsburg study. Prev Med. 2013;57:17–19. doi: 10.1016/j.ypmed.2013.02.014. [DOI] [PubMed] [Google Scholar]
- 34.Hudon C, Soubhi H, Fortin M. Relationship between multimorbidity and physical activity: secondary analysis from the Quebec health survey. BMC Public Health. 2008;8:304. doi: 10.1186/1471-2458-8-304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Raina PS, Wolfson C, Kirkland SA, Griffith LE, Oremus M, Patterson C, et al. The Canadian longitudinal study on aging (CLSA) Can J Aging. 2009;28:221–229. doi: 10.1017/S0714980809990055. [DOI] [PubMed] [Google Scholar]
- 36.Kirkland SA, Griffith LE, Menec VH, Wister A, Payette H, Wolfson C, et al. Mining a unique Canadian resource: the Canadian longitudinal study on aging. Can J Aging. 2015;34:366–377. doi: 10.1017/S071498081500029X. [DOI] [PubMed] [Google Scholar]
- 37.Canadian Longitudinal Study on Aging. 60-min. Questionnaire (Tracking Main Wave). 2018. Available from: https://clsa-elcv.ca/doc/446.
- 38.Canadian Longitudinal Study on Aging. Data Collection Tools. 2018. [Available from: https://www.clsa-elcv.ca/researchers/data-collection-tools.
- 39.Canadian Longitudinal Study on Aging. Maintaining Contact Questionnaire (Tracking and Comprehensive) Wave 1 Version. 2015. Available from: https://clsa-elcv.ca/doc/540.
- 40.Canadian Longitudinal Study on Aging. Sampling and Computation of Response Rates and Sample Weights for the Tracking (Telephone Interview) Participants and Comprehensive Participants. 2017. Available from: https://www.clsa-elcv.ca/doc/1041.
- 41.Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D. Prev Med. 1994;10:77–84. [PubMed] [Google Scholar]
- 42.Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol. 1981;36:428–434. doi: 10.1093/geronj/36.4.428. [DOI] [PubMed] [Google Scholar]
- 43.Fortin M, Stewart M, Poitras M, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10:142–151. doi: 10.1370/afm.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Rapoport J, Jacobs P, Bell NR, Klarenbach S. Refining the measurement of the economic burden of chronic diseases in Canada. Chronic Dis Can. 2004;25:13–21. [PubMed] [Google Scholar]
- 45.Rees D, Sabia J. Migraine headache and labor market outcomes. Health Econ. 2015;24:659–671. doi: 10.1002/hec.3052. [DOI] [PubMed] [Google Scholar]
- 46.Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of dementia. J Am Geriatr Soc. 2004;52:540–546. doi: 10.1111/j.1532-5415.2004.52159.x. [DOI] [PubMed] [Google Scholar]
- 47.Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing. 2008;37:505–512. doi: 10.1093/ageing/afn095. [DOI] [PubMed] [Google Scholar]
- 48.Sacco RL, Elkind M, Boden-Albala B, Lin I-F, Kargman DE, Hauser WA, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA. 1999;281(1):53–60. doi: 10.1001/jama.281.1.53. [DOI] [PubMed] [Google Scholar]
- 49.GBD 2016 Alcohol Collaborators Alcohol use and burden for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;12:987–1012. doi: 10.1016/S2215-0366(18)30337-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Starfield B. Global health, equity, and primary care. J Am Board Fam Med. 2007;20:511–513. doi: 10.3122/jabfm.2007.06.070176. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data used for this study cannot be made available by the authors, as Canadian Longitudinal Study on Aging (CLSA) data are released to researchers only with approval of the CLSA Data Access Committee for a specific project, and once ethics approval for the research project has been obtained from the appropriate Research Ethics Board, and a CLSA Access Agreement between the CLSA Custodian and the Applicant’s institution has been executed. Further information on the data access can be found at https://www.clsa-elcv.ca/data-access. This study was approved by the CLSA Data Access Committee and data were made available after approval was obtained from the Health Research Ethics Board at the University of Manitoba, and a CLSA Access Agreement was signed between the CLSA Custodian and the University of Manitoba.